Altimmune, Inc. (ALT)
5.47
-0.05
(-0.91%)
USD |
NASDAQ |
Dec 10, 12:40
Altimmune Profit Margin (Quarterly): -380.3K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -- |
| Eli Lilly & Co. | 31.72% |
| Pfizer Inc. | 21.32% |
| Terns Pharmaceuticals, Inc. | -- |
| Rhythm Pharmaceuticals, Inc. | -103.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.24% |
| Return on Assets | -49.17% |
| Return on Invested Capital | -53.60% |
| Gross Profit Margin (Quarterly) | -440.0% |
| Operating Margin (Quarterly) | -417.2K% |
| Return on Net Operating Assets | -7.20K% |